Tag: Pipeline

Celiac Disease – Intestinal damage of Gluten

Articles, Business Consultant, Pharma Consultant

Celiac Disease (Gluten-Sensitive Enteropathy) is a chronic, autoimmune, inflammatory disease of the small intestine characterized by damage...

Read More

Nonalcoholic Steatohepatitis (NASH): Highly Epidemic

Articles, Business Consultant, Pharma Consultant

Obesity and diabetes are a global epidemic contributing to an increasing prevalence of related systemic disorders, including non-alcoholic...

Read More

Notizia

Notizia

Read More

A promising immune stimulating target- “OX40”

Articles

For over 100 years, immunotherapy has played a significant role in the treatment of cancer. Immune stimulatory agents such as Toll-like...

Read More

Anticoagulants (VTE & AF) Therapeutics Market is estimated to reach $17.2 billion by 2020

Anti-coagulants, Atrial Fibrillation, Business Consultant, CVS Indications, Uncategorized, Venous Thromboembolism

The Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 2020...

Read More

Global VTE market is expected to grow to $4.75 billion by 2020 with a compound annual growth rate (CAGR) of 2.44%

Anti-coagulants, Business Consultant, Specialized Reports, Venous Thromboembolism

Venous Thromboembolism- Market Insights & Drugs Sales Forecast (VTE) -2020: New Report by DelveInsight suggests that the Global VTE...

Read More

Anticoagulants-Market Insights & Drugs Sales Forecast (VTE & AF)-2020- A DelveInsight Report

Anti-coagulants, Atrial Fibrillation, new therapeutic target, Specialized Reports, Venous Thromboembolism

According to DelveInsight researchers, the Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is...

Read More
Close